The multifaceted role of MTDH/AEG-1 in cancer progression

Clinical Cancer Research

Volumn 15, Issue 18, 2009, Pages 5615-5620

  Hu, Guohong ^a   Wei, Yong ^a   Kang, Yibin ^a,b  

^a PRINCETON UNIVERSITY   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CISPLATIN; DOXORUBICIN; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PACLITAXEL; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; WNT PROTEIN;

APOPTOSIS; ARTICLE; ASTROCYTE ELEVATED GENE 1; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL INVASION; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ASSESSMENT; CORRELATIONAL STUDY; ENZYME ACTIVATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE; GENE ACTIVITY; GENE FUNCTION; GENE OVEREXPRESSION; GLIOMA; HUMAN; LIVER CELL CARCINOMA; LUNG; MELANOMA; METADHERIN; METASTASIS; MOLECULAR CLONING; NEUROBLASTOMA; NONHUMAN; ONCOGENE C MYC; ONCOGENE H RAS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN DOMAIN; THERAPY EFFECT; TUMOR CELL; VASCULARIZATION;

ANIMALS; CELL ADHESION MOLECULES; DISEASE PROGRESSION; HUMANS; MEMBRANE PROTEINS; NEOPLASMS;

EID: 70349459893     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-0049     Document Type: Article

References (37)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
2. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006;12:895-904. (Pubitemid 44175140)
3. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006;127:679-695
4. Emdad L, Sarkar D, Su ZZ, et al. Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration. Pharmacol Ther 2007;114:155-170 (Pubitemid 46561534)
5. Kwong LN, Chin L. The metastasis problem gets stickier. Cancer Cell 2009;15:1-2.
6. Su ZZ, Kang DC, Chen Y, et al. Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene 2002;21:3592-3602 (Pubitemid 34587691)
7. Kang DC, Su ZZ, Sarkar D, Emdad L, Volsky DJ, Fisher PB. Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene 2005;353:8-15. (Pubitemid 40805356)
8. Brown DM, Ruoslahti E. Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 2004;5:365-374 (Pubitemid 38482072)
9. Britt DE, Yang DF, Yang DQ, et al. Identification of a novel protein, LYRIC, localized to tight junctions of polarized epithelial cells. Exp Cell Res 2004;300:134-148 (Pubitemid 39286223)
10. Sutherland HG, Lam YW, Briers S, Lamond AI, Bickmore WA. 3D3/lyric: a novel transmembrane protein of the endoplasmic reticulum and nuclear envelope, which is also present in the nucleolus. Exp Cell Res 2004;294:94-105. (Pubitemid 38229784)
11. Thirkettle HJ, Girling J, Warren AY, et al. Lyric/aeg-1 is targeted to different subcellular compartments by ubiquitinylation and intrinsic nuclear localization signals. Clin Cancer Res 2009;15:3003-3013
12. Emdad L, Sarkar D, Su ZZ, et al. Activation of the nuclear factor κB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res 2006;66:1509-1516 (Pubitemid 43259932)
13. Lee SG, Su ZZ, Emdad L, Sarkar D, Fisher PB. Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proc Natl Acad Sci U S A 2006;103:17390-17395 (Pubitemid 44788979)
14. Hunter T. Signaling-2000 and beyond. Cell 2000;100:113-127
15. Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature 2001;411:355-365
16. Malumbres M, Barbacid M. RAS oncogenes: the first 30 years. Nat Rev Cancer 2003;3:459-465
17. Sebolt-Leopold JS, Herrera R. Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer 2004;4:937-947 (Pubitemid 39626217)
18. Bodemann BO, White MA. Ral GTPases and cancer: linchpin support of the tumorigenic platform. Nat Rev Cancer 2008;8:133-140
19. Bader AG, Kang S, Zhao L, Vogt PK. Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 2005;5:921-929 (Pubitemid 41766781)
20. Rottmann S, Wang Y, Nasoff M, Deveraux QL, Quon KCA. TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3β/FBW7 loss of function. Proc Natl Acad Sci U S A 2005;102:15195-15200 (Pubitemid 41513358)
21. Lee SG, Su ZZ, Emdad L, Sarkar D, Franke TF, Fisher PB. Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene 2007;27:1114-1121 (Pubitemid 351253177)
22. Kikuno N, Shiina H, Urakami S, et al. Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene 2007;26:7647-7655 (Pubitemid 350224215)
23. Plas DR, Thompson CB. Akt activation promotes degradation of tuberin and FOXO3a via the proteasome. J Biol Chem 2003;278:12361-12366 (Pubitemid 36800220)
24. Baud V, Karin M. Is NF-κB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov 2009;8:33-40.
25. Karin M. Nuclear factor-κB in cancer development and progression. Nature 2006;441:431-436 (Pubitemid 44050137)
26. Karin M, Lin A. NF-κB at the crossroads of life and death. Nat Immunol 2002;3:221-227
27. Sarkar D, Park ES, Emdad L, Lee SG, Su ZZ, Fisher PB. Molecular basis of nuclear factor-κB activation by astrocyte elevated gene-1. Cancer Res 2008;68:1478-1484 (Pubitemid 351346856)
28. Yoo BK, Emdad L, Su ZZ, et al. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest 2009;119:465-477
29. Hu G, Chong RA, Yang Q, et al. MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell 2009;15:9-20.
30. Liu H, Song X, Liu C, Xie L, Wei L, Sun R. Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells. J Exp Clin Cancer Res 2009;28:19.
31. Li J, Zhang N, Song LB, et al. Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res 2008;14:3319-3326
32. Kim DH, Mohapatra G, Bollen A, Waldman FM, Feuerstein BG. Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridization. Int J Cancer 1995;60:812-819
33. Ried T, Just KE, Holtgreve-Grez H, et al. Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. Cancer Res 1995;55:5415-5423
34. Warr T, Ward S, Burrows J, et al. Identification of extensive genomic loss and gain by comparative genomic hybridisation in malignant astrocytoma in children and young adults. Genes Chromosomes Cancer 2001;31:15-22. (Pubitemid 32274128)
35. Bergamaschi A, Kim YH, Wang P, et al. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosomes Cancer 2006;45:1033-1040 (Pubitemid 44435537)
36. Yu C, Chen K, Zheng H, et al. Overexpression of astrocyte elevated gene-1 (aeg-1) is associated with esophageal squamous cell carcinoma (escc) progression and pathogenesis. Carcinogenesis 2009;30:894-901.
37. Ash SC, Yang DQ, Britt DE. LYRIC/AEG-1 overexpression modulates BCCIPα protein levels in prostate tumor cells. Biochem Biophys Res Commun 2008;371:333-338